Table 1.
Baseline characteristics of patients with previous SARS‑CoV‑2 infection and other vaccine recipients by vaccine type
| CoronaVac | Comirnaty | |||
|---|---|---|---|---|
| Patient with previous SARS‑CoV‑2 infection | Patient without previous SARS‑CoV‑2 infection | Patient with previous SARS‑CoV‑2 infection | Patient without previous SARS‑CoV‑2 infection | |
| N | 943 | 511,802 | 979 | 625,781 |
| Sex = Male (%) | 411 (43.6) | 244,550 (47.8) | 1459 (49.0) | 288,488 (46.1) |
| Age (mean (SD)) | 51.12 (13.00) | 53.22 (13.67) | 42.60 (14.77) | 45.88 (14.95) |
| CCI (%) | ||||
| 0 | 848 (89.9) | 461,848 (90.2) | 2768 (92.9) | 583,535 (93.2) |
| 1–2 | 91 (9.7) | 47717 (9.3) | 200 (6.7) | 40,193 (6.4) |
| 3–4 | 2 (0.2) | 1126 (0.2) | 7 (0.2) | 913 (0.1) |
| ≥5 | 2 (0.2) | 1111 (0.2) | 4 (0.1) | 1140 (0.2) |
Abbreviation: CCI, Charlson Comorbidity Index.